These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Antibacterial activity of sparfloxacin against experimental renal infections in mice. Georgopoulos A; Feistauer SM; Graninger W; Pfleger S; Georgopoulos M Antimicrob Agents Chemother; 1992 Feb; 36(2):505-7. PubMed ID: 1318685 [TBL] [Abstract][Full Text] [Related]
63. Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections. Meinen JB; McClure JT; Rosin E Am J Vet Res; 1995 Sep; 56(9):1219-24. PubMed ID: 7486402 [TBL] [Abstract][Full Text] [Related]
64. Initial clinical experience with clinafloxacin in the treatment of serious infections. Tack KJ; McGuire NM; Eiseman IA Drugs; 1995; 49 Suppl 2():488-91. PubMed ID: 8549411 [No Abstract] [Full Text] [Related]
65. A critical review of the fluoroquinolones: focus on respiratory infections. Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ Drugs; 2002; 62(1):13-59. PubMed ID: 11790155 [TBL] [Abstract][Full Text] [Related]
66. Use of animal models in evaluation of the quinolones. Sande MA; Brooks-Fournier RA; Gerberding JL Rev Infect Dis; 1988; 10 Suppl 1():S113-6. PubMed ID: 3279487 [TBL] [Abstract][Full Text] [Related]
67. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Willcox MD Clin Exp Optom; 2011 Mar; 94(2):161-8. PubMed ID: 21083760 [TBL] [Abstract][Full Text] [Related]
68. [Resistance and new antibiotic strategies. New antistaphylococcal antibiotics]. Bergogne-Bérézin E Presse Med; 2000 Dec; 29(37):2023-7. PubMed ID: 11155724 [TBL] [Abstract][Full Text] [Related]
69. Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Ocheretyaner ER; Park TE Expert Rev Anti Infect Ther; 2018 Jul; 16(7):523-530. PubMed ID: 29911455 [TBL] [Abstract][Full Text] [Related]
70. Use of newer quinolones for the treatment of intraabdominal infections: focus on clinafloxacin. Nord CE Infection; 1999; 27(3):166-72. PubMed ID: 10378126 [No Abstract] [Full Text] [Related]
71. Bacterial resistance to fluoroquinolones: mechanisms and patterns. Hooper DC Adv Exp Med Biol; 1995; 390():49-57. PubMed ID: 8718601 [No Abstract] [Full Text] [Related]
72. Comparative therapeutic efficacy of clinafloxacin in leucopenic mice. Shapiro MA; Dever JA; Sesnie JC; VanderRoest SR J Antimicrob Chemother; 1997 Feb; 39(2):273-6. PubMed ID: 9069553 [TBL] [Abstract][Full Text] [Related]